The TEVAR Center

Filter Your Results

 

News

 

Cook Medical Resolves 2014 FDA Warning Letter

September 11, 2018 -- Cook Medical announced it has received a close-out notification from the US Food and Drug Administration, resolving the warning letter issued to the comp…

Feasibility Study Begins for the Gore Ascending Stent Graft to Treat Type A Dissection

August 27, 2018 -- Gore & Associates, Inc. announced the initiation of the FDA-approved Gore ARISE study, a multicenter, early feasibility study evaluating the endovascula…

Residual Dissection and False Lumen Aneurysm After TEVAR

Moderator: Mark Farber, MD
Panel: Yazan Duwayri, MD; Matthew J. Eagleton, MD; William D. Jordan Jr, MD; Tilo Kölbel, MD, PhD; and Eric L.G. Verhoeven, MD, PhD

August 2018—CASE PRESENTATION A 67-year-old man underwent thoracic endovascular aortic repair (TEVAR) for acute type B dissection at a neighboring institution 3 years prior to this pre…

SVS Publishes New Guidelines for Follow-Up Imaging After Vascular Procedures

July 31, 2018 -- The Society for Vascular Surgery (SVS) announced the publication of new clinical practice guidelines on follow-up imaging after vascular arterial surgery. The…

Merit Medical Named Distributor for QXMédical's Q50 Plus EVAR Device

July 12, 2018 -- Merit Medical Systems, Inc. announced that it has been named the exclusive global distributor of QXMédical's Q50 Plus stent graft balloon catheter.…

Gore's TAG Conformable Thoracic Stent Graft With Active Control System Introduced in Australia

July 2, 2018 -- Gore & Associates announced the commercial introduction in Australia of its TAG conformable thoracic stent graft with Active Control system, which was…

Labeling Considerations for Devices With Lubricious Coatings Addressed in FDA Draft Guidance

June 20, 2018 -- The US Food and Drug Administration (FDA) has issued a draft guidance document on labeling considerations for devices containing lubricious coatings used in t…

Study Reports on National Trends in Treatment of Thoracic Aortic Aneurysm and Type B Dissection

June 5, 2018 -- A study that sought to define, compare, and contrast the national trends in hospital admissions, invasive treatments, and inpatient mortality of patients with …

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.